Delivery Order SPE2DB24D2101-SPE2DB25FKMWT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) with a ceiling value of $2,741.22. This firm fixed-price delivery order, issued on August 14, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract is set for completion by August 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of RotaTeq vaccine (2mL formulation) valued at $10,655.80. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award of the pharmaceutical product. The order is scheduled for ultimate completion on August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,286.08 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2ML units. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, operates under firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.66 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2 milliliter units. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not carry a set-aside designation, indicating it was competed among...
- The Defense Logistics Agency awarded a $3,126.67 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on September 16, 2025, with completion targeted for September 17, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML) on September 10, 2025, with a ceiling value of $13,268.58. This firm fixed-price delivery order, which carries an ultimate completion date of September 11, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency (DLA) awarded a $4,150.39 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,671.82 to AmerisourceBergen Drug Corp for RotaTeq Vaccine 2ML on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.10 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML formulation) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of RotaTeq vaccine (2 mL formulation) valued at $16,350.33 under a firm fixed-price contract structure. This non-competitive delivery order is scheduled for completion by September 9, 2025, with performance occurring at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract action under...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMWTDelivery Order
The Defense Logistics Agency awarded a $3,844.54 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of RotaTeq vaccine (2ML). The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside contract utilizes the standard delivery order mechanism, with performance scheduled for completion by July 30, 2025. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems through its comprehensive SPE2DX vehicle. The RotaTeq vaccine delivery order exemplifies the company's role in supplying essential immunization products and vaccines to support military health programs. AmerisourceBergen's substantial federal contract portfolio demonstrates its capability to fulfill competitive federal requirements across a broad spectrum of pharmaceutical and medical supply categories, positioning it as a key vendor within the DLA's Medical Supply Chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 7/29/25 |